Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

EMA updates product information for AZ COVID-19 vaccine

PRAC reaffirms opinion that AZ vaccine's efficacy outweighs very rare likelihood of developing a blood clotting disorder

- PMLiVE

Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets

Avalere Health

- PMLiVE

Now that COVID-19 vaccines have been approved, it’s our turn, healthcare communicators

The more people who are protected against COVID-19, the better it will be for the health of our global community

Wearable Technologies for Detecting Pre-Symptomatic Illness and Infections

Dr. Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. Among...

Impetus Digital

Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity

Julia Walsh, CEO of Brand Medicine International, explores the concept of “search listening” in healthcare, and how it can be used to inform brand strategy, improve patient-centricity, and fight scientific...

Impetus Digital

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Inizio

Top 10 Tips for Running a Successful Virtual Event

Based on 13 years of experience in virtualizing life science meetings and events

Impetus Digital

- PMLiVE

UK plans to launch new national health agency focused on tackling pandemics

The UK Health Security Agency will protect against future health threats

- PMLiVE

EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies

EU leaders are set to meet today to discuss proposed vaccine export plans

- PMLiVE

AZ publishes primary analysis for COVID-19 vaccine, showing slightly lower efficacy of 76%

AZ previously announced vaccine efficacy of 79% in US-based trial

- PMLiVE

Responsibly growing our talent pool

Talent remains the healthcare communications sector’s most important asset and its biggest challenge

Case studies

[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials

See how three pharma companies supported the provision of virtual and on-demand scientific meetings for HCPs during COVID-19.

EPG Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links